DALLAS--(BUSINESS WIRE)--Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, has launched an investigation of Ekso Bionics Holdings, Inc. (“Ekso”) (NASDAQ: EKSO) and several officers and directors for possible violations of federal securities laws.
The firm is investigating potential legal claims against the officers and Board of Directors of Ekso. If you are an affected Ekso shareholder and want to learn more about the investigation, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com, or call toll free at (888) 809-2750. There is no cost or fee to you.
The firm seeks to determine if the defendants violated certain provisions of the Securities Exchange Act of 1934. Specifically, the investigation relates to Ekso’s announcement on December 14, 2017, advising investors that its internal control over financial reporting as of December 31, 2016 should no longer be relied upon and that a material weakness in its internal control over financial reporting existed as of such date. Then on December 27, 2017, Ekso filed an amended annual report for 2016 and amended quarterly reports for the first three quarters of 2017. On this news, Ekso’s share price declined.
The Briscoe Law Firm, PLLC is a full service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters.
